Status:
COMPLETED
The Liver in the World Trade Center Health Program General Responder Cohort and Controls
Lead Sponsor:
Icahn School of Medicine at Mount Sinai
Collaborating Sponsors:
National Institutes of Health (NIH)
Conditions:
Steatosis of Liver
NASH - Nonalcoholic Steatohepatitis
Eligibility:
All Genders
55-80 years
Brief Summary
This project investigates whether exposure to the World Trade Center Attack is a risk factor for liver injury.
Detailed Description
This is a prospective cross-sectional study of liver disease in individuals who meet the United States Preventive Services Task Forces guidelines for lung cancer screening because they are between 55 ...
Eligibility Criteria
Inclusion
- Male or Female between 55 and 80 years of age
- 30 year pack-history of smoking and are either current smokers or who quit during the past 15 years.
- Individuals who are members of the World Trade Center General Responder Cohort or Subjects who meet the United States Preventive Services Task Forces guidelines for lung cancer screening
Exclusion
- None
Key Trial Info
Start Date :
May 8 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 11 2021
Estimated Enrollment :
340 Patients enrolled
Trial Details
Trial ID
NCT03858920
Start Date
May 8 2018
End Date
June 11 2021
Last Update
July 12 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Icahn School of Medicine at Mount Sinai
New York, New York, United States, 10029